Skip to main content
Log in

A much-anticipated FDA reform bill is signed into law: Progress and compromise

  • Invited Commentary
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. US Food and Drug Administration: Law Strengthens FDA. Available at http://www.fda.gov/oc/initiatives/advance/fdaaa.html. Accessed October 9, 2007.

  2. DefendingScience.org: An Open Letter to Sen. Kennedy et al. Available at http://www.defendingscience.org/newsroom/upload/PDUFA_Open-Letter.pdf. Accessed October 9, 2007.

  3. U.S. Senate Committee on Health, Education, Labor, & Pensions: Testimony to the U.S. Senate Committee on Health, Education, Labor, and Pensions. Building a 21st Century FDA: Proposals to Improve Drug Safety and Innovation. Available at http://help.senate.gov/Hearings/2006_11_16/Nissen.pdf. Accessed October 9, 2007.

  4. Institute of Medicien of the National Academies: Assessment of the U. S. Drug Safety System. Available at http://www.iom.edu/CMS/3793/26341.aspx. Accessed October 9, 2007.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven E. Nissen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nissen, S.E. A much-anticipated FDA reform bill is signed into law: Progress and compromise. Curr Diab Rep 8, 79–80 (2008). https://doi.org/10.1007/s11892-008-0014-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-008-0014-1

Keywords

Navigation